FDA Alerts

March 24, 2016

FDA IVC Filter News

Almost since it became known that IVC filters designed to fight blood clots could instead cause serious injuries to patients, FDA news of IVC filters has […]
March 23, 2016

Essure FDA Investigation

What is a clear sign that Essure birth control devices are defective? The U.S. Food and Drug Administration is launching a probe of the contraceptive device. […]
June 24, 2012

Paxil and Pregnancy

Back in 2006, the Food and Drug Administration (FDA) announced that research evaluations of the prescription antidepressant Paxil discovered that taking Paxil during pregnancy, specifically during […]
March 28, 2012

Pradaxa FDA Alert

In December of 2011, the United States Food and Drug Administration (FDA) released a Safety Announcement regarding recent studies conducted about Pradaxa causing internal bleeding. The […]
March 4, 2011

FDA Alert: Topamax Oral Clefts Risk in Infants

FDA Drug Safety Communication: Risk of Oral Clefts in Children Born to Mothers Taking Topamax (topiramate) The U.S. Food and Drug Administration (FDA) is informing the […]
March 12, 2010

Baby Slings Can Cause Infant Suffocation

The U.S. Consumer Product Safety Commission (CPSC) is advising parents and caregivers to be cautious when using infant slings for babies younger than four months of […]
January 5, 2010

ev3 Endovascular Inc. Trailblazer Support Catheter Recall

ev3 Endovascular, Inc. and the FDA notified healthcare professionals of a Class I Recall of the Trailblazer Support Catheter. This device may crack near the radiopaque […]
October 1, 2009

New USP Standards for Heparin Products

New USP Standards for Heparin Products Will Result in Decreased Potency Adjustments may be Needed to Achieve Desired Anticoagulant Effect in Some Patients New Heparin to […]
August 24, 2009

FDA Reviewing Weight Loss Drug Orlistat

FDA Issues Early Communication about Ongoing Safety Review of Orlistat. Weight loss drug review includes both prescription drug Xenical and OTC drug Alli. The U.S. Food […]